LeuSys Technologies - About the company
LeuSys Technologies is an unfunded company based in Atlanta (United States). It operates as a Manufacturer of active pharmaceutical ingredients and chemical pharmaceutical preparation products. LeuSys Technologies has not raised any funding yet. The company has 1796 active competitors, including 89 funded and 199 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.
Company Details
Manufacturer of active pharmaceutical ingredients and chemical pharmaceutical preparation products. Operations include the development and production of drugs for cardiovascular, immune, antibiotic, and various therapeutic applications. The facility maintains capabilities for research, laboratory development, and industrial manufacturing of chemical compounds and pharmaceutical formulations.
Key Metrics
Location
Atlanta, United States
Stage
Unfunded
Ranked
536th among 1796 active competitors
Employee Count
1 as on Jun 30, 2026
Sign up to download LeuSys Technologies' company profile
LeuSys Technologies's funding and investors
LeuSys Technologies has not raised any funding rounds yet.
LeuSys Technologies' founders and board of directors
Founder? Claim ProfileLeuSys Technologies' employee count trend
LeuSys Technologies has 1 employees as of Jun 26. Here is LeuSys Technologies's employee count trend over the years:
Uncover LeuSys Technologies' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
LeuSys Technologies's Competitors and alternates
Top competitors of LeuSys Technologies include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of LeuSys Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 81/100 | |
2nd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 81/100 | |
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 80/100 | |
4th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
5th |  Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 74/100 | |
6th |  AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 73/100 | |
7th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
8th |  Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 70/100 | |
9th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
10th | Genentech 1976, San Francisco (United States), Acquired | R&D company focused on manufacturing drugs for multiple therapeutic areas | $72.5M | 69/100 | |
536th | LeuSys Technologies Atlanta (United States), Unfunded | Manufacturer of active pharmaceutical ingredients and chemical pharmaceutical preparation products | - | - | 22/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on LeuSys Technologies's competitors? Click here to see the top ones
LeuSys Technologies's Investments and acquisitions
LeuSys Technologies has made no investments or acquisitions yet.
Reports related to LeuSys Technologies
Here is the latest report on LeuSys Technologies's geography:
Are you a Founder ?
FAQs about LeuSys Technologies
Explore our recently published companies
- NIMBLE:BI - Umea based, 2019 founded, Unfunded company
- Project More - India based, 2022 founded, Unfunded company
- Agify.io - Roskilde based, 2019 founded, Unfunded company
